Breathe Well Live Well
Medical Xpress |
Extreme heat and precipitation linked to more severe asthma requiring hospitalization
Medical Xpress Based on over a decade of asthma hospitalization data (115,923 cases from 2000-2012), researchers observed higher risk of asthma hospitalization after extreme heat or extreme precipitation events. The increases in risk were particularly high during … |
View full post on asthma – Google News
|
HDM SLIT tablet can reduce risk of moderate or severe asthma exacerbation
News-Medical.net The addition of a house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet to maintenance medications improved time to first moderate or severe asthma exacerbation during a period of inhaled corticosteroid (ICS) reduction among adults with … House dust mite immunotherapy in adults with allergic asthma |
View full post on asthma – Google News
|
Impacts of coexisting bronchial asthma on severe exacerbations in mild | COPD
Dove Medical Press Backround: Acute exacerbations are major drivers of COPD deterioration. However, limited data are available for the prevalence of severe exacerbations and impact of asthma on severe exacerbations, especially in patients with mild-to-moderate COPD. |
View full post on asthma – Google News
Condition: Asthma
Intervention: Drug: VR588
Sponsors: Imperial College London; Vectura Limited
Recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Angiopoietin-2 linked to severe asthma, exacerbations
Healio Patients with increased Angiopoietin-2 serum levels are more likely to have severe or refractory asthma and have repeat severe exacerbations, according to research. “Our study has confirmed and extended previous observations suggesting an imbalance … |
View full post on asthma – Google News
ABC Online |
Bronchial thermoplasty could be a 'game changer' for severe asthma
ABC Online For very severe asthma suffers, everyday life can be tough. Each day can be punctuated by wheezing, breathlessness and chest tightness. But a promising medical procedure that effectively "burns" the inside of the bronchial tubes to widen the airways … |
View full post on asthma – Google News
|
Benralizumab: a unique IL-5 inhibitor for severe asthma
Dove Medical Press Abstract: The presence of eosinophilic inflammation is a characteristic feature of chronic and acute inflammation in asthma. An estimated 5%–10% of the 300 million people worldwide who suffer from asthma have a severe form. Patients with eosinophilic … |
View full post on asthma – Google News
ABC Online |
Severe asthma sufferers offered hope in form of bronchial thermoplasty
ABC Online A relatively new medical procedure could dramatically improve the lives of severely asthmatic Australians, a year-long trial has found. The national trial saw 17 Australians undergo bronchial thermoplasty, a procedure to open the lungs' airways by … Surgery for asthma hailed a 'revolution' |
View full post on asthma – Google News
Lung Disease News |
FDA Approves Teva's Cinqair for the Treatment of Severe Asthma
Pharmaceutical Technology Magazine (press release) (blog) FDA approved Teva Pharmaceutical's Cinqair (reslizumab) on March 23, 2016 for use with other asthma medicines for the maintenance treatment of severe asthma in patients 18 years and older. Cinqair is approved for patients who have a history of severe … FDA Approves Teva's Asthma Drug Cinqair as Add-on Treatment Nucala and Cinqair for the Treatment of Severe Asthma |
View full post on asthma – Google News
Medscape |
FDA Approves Cinqair To Treat Severe Asthma
Pharmacy Practice News The FDA has approved reslizumab (Cinqair, Teva Pharmaceuticals) as an add-on maintenance treatment for patients aged 18 years and older with an eosinophilic phenotype asthma, who have a history of severe exacerbations despite receiving their current … FDA approves reslizumab to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma Cinqair Receives FDA Approval As Treatment For Severe Asthma |
View full post on asthma – Google News